Published in J Neuroophthalmol on December 01, 2004
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology (2006) 4.72
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain (2011) 3.48
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol (2010) 2.96
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol (2012) 2.79
Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology (2012) 2.48
Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol (2007) 2.44
The King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort. J Neurol Sci (2011) 2.43
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology (2013) 2.43
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol (2013) 2.22
Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol (2008) 2.20
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology (2013) 2.06
Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. Arch Neurol (2002) 2.05
Laser pointer visual field screening. J Neuroophthalmol (2003) 2.03
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol (2009) 1.85
Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol (2011) 1.80
Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol (2006) 1.66
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics (2011) 1.57
Near infrared muscle spectroscopy in patients with Friedreich's ataxia. Muscle Nerve (2002) 1.53
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS. Neurology (2012) 1.51
Functional visual loss in idiopathic intracranial hypertension. Ophthalmology (2009) 1.51
Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology (2013) 1.46
Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies. J AAPOS (2011) 1.45
Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology. Brain (2010) 1.45
The role of unilateral temporal artery biopsy. Ophthalmology (2003) 1.44
Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol (2009) 1.43
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia (2007) 1.37
Optic nerve biopsy in the management of progressive optic neuropathy. J Neuroophthalmol (2012) 1.37
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol (2012) 1.36
Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology (2013) 1.36
Sports-related concussion: Anonymous survey of a collegiate cohort. Neurol Clin Pract (2013) 1.35
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler (2010) 1.29
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord (2010) 1.29
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol (2012) 1.27
The Neurological Complications of Nutritional Deficiency following Bariatric Surgery. J Obes (2012) 1.27
Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol (2011) 1.25
Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol (2008) 1.25
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol (2008) 1.20
One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol (2011) 1.17
Saccades and memory: baseline associations of the King-Devick and SCAT2 SAC tests in professional ice hockey players. J Neurol Sci (2013) 1.14
Predictors of future publication record and academic rank in a cohort of neurology residents. Neurology (2006) 1.13
Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma. Ann Neurol (2014) 1.12
Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci (2009) 1.11
Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol (2010) 1.10
The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One (2011) 1.09
Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol (2011) 1.07
Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessment. J Neurol Sci (2004) 1.04
Multiple sclerosis: can retinal imaging accurately detect optic neuritis? Nat Rev Neurol (2010) 1.01
Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol (2002) 0.95
Antioxidant use in Friedreich ataxia. J Neurol Sci (2007) 0.95
Performance measures in Friedreich ataxia: potential utility as clinical outcome tools. Mov Disord (2005) 0.95
Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Mov Disord (2003) 0.91
Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study. J Neuroophthalmol (2012) 0.90
Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. J Neuroophthalmol (2002) 0.90
Adding Vision to Concussion Testing: A Prospective Study of Sideline Testing in Youth and Collegiate Athletes. J Neuroophthalmol (2015) 0.89
Health related quality of life measures in Friedreich Ataxia. J Neurol Sci (2008) 0.87
Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci (2011) 0.86
Retinal damage and vision loss in African American multiple sclerosis patients. Ann Neurol (2015) 0.84
Combined optic neuropathy and myelopathy secondary to copper deficiency. Surv Ophthalmol (2010) 0.83
Analysis of the visual system in Friedreich ataxia. J Neurol (2013) 0.83
Pituitary apoplexy causing optic neuropathy and horner syndrome without ophthalmoplegia. J Neuroophthalmol (2003) 0.82
Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis. J Neuroophthalmol (2013) 0.82
The latest on optical coherence tomography. J Neuroophthalmol (2014) 0.80
Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis. Mult Scler (2013) 0.79
Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J Neurol Sci (2010) 0.79
Sports-related concussion testing. Curr Neurol Neurosci Rep (2012) 0.79
Diagnostic tests for concussion: is vision part of the puzzle? J Neuroophthalmol (2015) 0.78
The neuro-ophthalmology of multiple sclerosis. Continuum (Minneap Minn) (2010) 0.78
Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life. J Neuroophthalmol (2015) 0.78
Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography. Am J Ophthalmol (2006) 0.78
Current concepts in pseudotumor cerebri. Curr Opin Neurol (2016) 0.78
Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst (2011) 0.77
Multiple sclerosis and the ophthalmologist. Compr Ophthalmol Update (2007) 0.77
Approach to optic neuropathies: clinical update. Neurologist (2010) 0.77
Residency training: the King-Devick test and sleep deprivation: study in pre- and post-call neurology residents. Neurology (2012) 0.77
Optic neuritis and the evaluation of visual impairment in multiple sclerosis. Continuum (Minneap Minn) (2013) 0.77
Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia. Alzheimer Dis Assoc Disord (2016) 0.76
20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought? J Neuroophthalmol (2016) 0.76
Objective characterization of the relative afferent pupillary defect in MS. J Neurol Sci (2012) 0.76
Education research: a new system for reducing patient nonattendance in residents' clinic. Neurology (2010) 0.75
Tension pneumocephalus after endoscopic sinus surgery: case report of repair and management in absence of obvious skull base defect. Ear Nose Throat J (2008) 0.75
All choked up about the pseudotumor cerebri syndrome. Neurology (2013) 0.75
In reply: the King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort. J Neurol Sci (2013) 0.75
The 57th Annual Meeting of the American Academy of Neurology, Miami, Florida, April 9-16, 2005. J Neuroophthalmol (2005) 0.75
54th annual meeting of the American Academy of Neurology, Denver, Colorado, April 13-20, 2002. J Neuroophthalmol (2003) 0.75
Fear sensitivity and the psychological profile of patients with psychogenic nonepileptic seizures. Epilepsy Behav (2006) 0.75
Pupil-involving third nerve palsy as a manifestation of anti-myelin-associated glycoprotein neuropathy. J Neuroophthalmol (2011) 0.75
Tumoral Presentation of Homonymous Hemianopia and Prosopagnosia in Cerebral Amyloid Angiopathy-Related Inflammation. J Neuroophthalmol (2017) 0.75
OCT and NMO: are there methods to our madness? J Neuroophthalmol (2013) 0.75
Endocrine and metabolic deficiency. Ophthalmol Clin North Am (2004) 0.75
Visual Structure and Function in Collision Sport Athletes. J Neuroophthalmol (2017) 0.75
Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort. J Neuroophthalmol (2017) 0.75